CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
Human BioMolecular Research Institute |
Dr. John R Cashman |
Early Translational IV |
Improving Existing Drugs for Long QT Syndrome type 3 (LQT3) by hiPSC Disease-in-Dish Model |
$6,361,369 |
Numerate, Inc. |
Dr. John H Griffin |
Early Translational IV |
Use of human iPSC-derived neurons from Huntington’s Disease patients to develop novel, disease-modifying small molecule structural corrector drug candidates targeting the unique, neurotoxic conformation of mutant huntingtin |
$520,015 |
University of California, Los Angeles |
Dr. Jerome A. Zack Ph.D. |
Early Translational IV |
Stem Cell Programming With Chimeric Antigen Receptors to Eradicate HIV Infection |
$4,925,166 |
University of California, Los Angeles |
Dr. Gerald Lipshutz |
Early Translational IV |
Gene therapy-corrected autologous hepatocyte-like cells from induced pluripotent stem cells for the treatment of pediatric single enzyme disorders |
$1,801,629 |
University of California, Los Angeles |
Dr. Donald B. Kohn PhD |
Early Translational IV |
Beta-Globin Gene Correction of Sickle Cell Disease in Hematopoietic Stem Cells |
$1,651,884 |
Salk Institute for Biological Studies |
Dr. Inder M. Verma |
Early Translational IV |
Development of a cell and gene based therapy for hemophilia |
$2,298,634 |
The Scintillon Institute |
Dr. Stuart A Lipton |
Early Translational IV |
Programming Human ESC-derived Neural Stem Cells with MEF2C for Transplantation in Stroke |
$1,103,185 |
Sanford Burnham Prebys Medical Discovery Institute |
Dr. Stuart A Lipton |
Early Translational IV |
Programming Human ESC-derived Neural Stem Cells with MEF2C for Transplantation in Stroke |
$1,020,815 |
University of California, San Diego |
Professor Alysson R Muotri |
Early Translational IV |
A drug-screening platform for autism spectrum disorders using human astrocytes |
$1,656,456 |
Cedars-Sinai Medical Center |
Dr. Dan Gazit |
Early Translational IV |
Gene Targeting to Endogenous Stem Cells for Segmental Bone Fracture Healing |
$5,121,514 |
Stanford University |
Dr. Michele Calos |
Early Translational IV |
Engineered iPSC for therapy of limb girdle muscular dystrophy type 2B |
$1,876,253 |
Gladstone Institutes, J. David |
Dr. Steve M. Finkbeiner |
Early Translational IV |
Development of Novel Autophagy Inducers to Block the Progression of and Treat Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Diseases |
$2,049,053 |
University of California, Irvine |
Dr. Magdalene J Seiler |
Early Translational IV |
Restoring vision by sheet transplants of retinal progenitors and retinal pigment epithelium (RPE) derived from human embryonic stem cells (hESCs) |
$3,998,948 |
ViaCyte, Inc. |
Howard Foyt |
Strategic Partnership I |
Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes |
$9,475,070 |
Bluebird Bio |
David M. Davidson |
Strategic Partnership I |
A Phase 1/2, Open Label Study Evaluating the Safety and Efficacy of Gene Therapy in Subjects with β-Thalassemia by Transplantation of Autologous Hematopoietic Stem Cells Transduced with the Lentiviral Vector LentiGlobin® Encoding the Human β-A-T87Q-… |
$0 |
FUJIFILM Cellular Dynamics |
Deborah Requesens |
hPSC Repository |
The CIRM Human Pluripotent Stem Cell Biorepository – A Resource for Safe Storage and Distribution of High Quality iPSCs |
$9,942,175 |
Cellular Dynamics International |
Dr. Thomas J Novak |
hiPSC Derivation |
Generation and characterization of high-quality, footprint-free human induced pluripotent stem cell lines from 3,000 donors to investigate multigenic diseases |
$16,000,000 |
University of California, San Diego |
Dr. Joseph G. Gleeson |
Tissue Collection for Disease Modeling |
CIRM Tissue Collection for Neurodevelopmental Disabilities |
$830,426 |
University of California, San Diego |
Dr. Kang Zhang M.D. |
Tissue Collection for Disease Modeling |
Generation of fibroblast cell lines in patients with common blinding eye diseases |
$1,034,425 |
Stanford University |
Dr. Joseph C. Wu |
Tissue Collection for Disease Modeling |
Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases |
$1,291,832 |
University of California, San Diego |
Dr. James Brewer |
Tissue Collection for Disease Modeling |
Collection of skin biopsies to prepare fibroblasts from patients with Alzheimer’s disease and cognitively healthy elderly controls |
$643,693 |
Stanford University |
Dr. Joachim Franz Hallmayer |
Tissue Collection for Disease Modeling |
Induced pluripotent stem cells from children with autism spectrum disorders |
$530,265 |
University of California, Los Angeles |
Dr. Brigitte N Gomperts |
Tissue Collection for Disease Modeling |
Using human induced pluripotent stem cells to improve our understanding of Idiopathic Pulmonary Fibrosis |
$811,231 |
University of California, San Francisco |
Jacquelyn J Maher |
Tissue Collection for Disease Modeling |
iPSC-derived Hepatocytes as Platforms for Research in Viral Hepatitis and Non-alcoholic Steatohepatitis |
$791,680 |
Reza Ardehali |
Dr. Reza Ardehali MD, PhD |
New Faculty Physician Scientist |
Medical School Loan Repayment Program |
$35,511 |
Tippi C. Mackenzie |
Dr. Tippi C. Mackenzie MD |
New Faculty Physician Scientist |
Medical School Loan Repayment Program |
$36,436 |
Ali Nsair |
Ali Nsair |
New Faculty Physician Scientist |
Medical School Loan Repayment Program |
$120,312 |
University of California, San Francisco |
Dr. Tippi C. MacKenzie |
New Faculty Physician Scientist |
In Utero Embryonic Stem Cell Transplantation to Treat Congenital Anomalies |
$2,661,742 |
Cedars-Sinai Medical Center |
Dr. Robert H Baloh |
New Faculty Physician Scientist |
Human iPSC modeling and therapeutics for degenerative peripheral nerve disease |
$3,031,737 |
Stanford University |
Alan G Cheng |
New Faculty Physician Scientist |
Enhancing hair cell regeneration in mouse and human inner ear |
$3,088,525 |
University of California, San Francisco |
Dr. Ophir Klein MD, PhD |
New Faculty Physician Scientist |
Stem cell therapy for inflammatory bowel disease |
$3,019,013 |
Stanford University |
Michelle Monje |
New Faculty Physician Scientist |
White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain” |
$2,800,526 |
University of California, San Francisco |
Jason Harris Pomerantz |
New Faculty Physician Scientist |
Characterization of Human Skeletal Muscle Stem Cells for Clinical Application |
$2,959,014 |
University of California, San Francisco |
Ann Capela Zovein |
New Faculty Physician Scientist |
Human endothelial reprogramming for hematopoietic stem cell therapy. |
$2,197,683 |
University of California, Davis |
Emanual Michael Maverakis |
New Faculty Physician Scientist |
Tunable hydrogels for therapeutic delivery of multipotent stem cells. |
$2,771,903 |
University of California, Los Angeles |
Dr. Ali Nsair MD |
New Faculty Physician Scientist |
Human Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cells for Cardiac Cell Therapy. |
$2,316,894 |
Children’s Hospital of Los Angeles |
Dr. Tracy Cannon Grikscheit M.D. |
New Faculty Physician Scientist |
The generation and expansion of tissue-engineered small intestine from human stem/ progenitor cells: a preclinical study of functional translation |
$3,146,160 |
University of California, San Diego |
Dr. Mana M Parast |
New Faculty Physician Scientist |
Human pluripotent stem cell-based therapeutics for preeclampsia |
$2,974,750 |
University of California, Los Angeles |
Dr. Reza Ardehali MD, PhD |
New Faculty Physician Scientist |
Preclinical evaluation of human embryonic stem cell-derived cardiovascular progenitors in a large animal model |
$2,930,388 |
Gladstone Institutes, J. David |
Ms. Shannon Noonan |
Creativity Awards |
Gladstone Summer Scholars (GSS) internship program |
$35,044 |
City of Hope, Beckman Research Institute |
Dr. Paul M. Salvaterra |
Creativity Awards |
Creativity Award Program in Stem Cell Biology for California High School Students |
$260,825 |
University of California, Davis |
Gerhard Gerhard Bauer |
Creativity Awards |
Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility |
$250,064 |
University of California, San Francisco |
Katherine Nielsen |
Creativity Awards |
UCSF SEP High School Intern Program |
$168,947 |
University of California, Santa Barbara |
Lina Kim |
Creativity Awards |
Research Mentorship Program-Immersing High School Students in College Research |
$280,726 |
UCSF Benioff Children’s Hospital Oakland |
Vasanthy Narayanaswami |
Creativity Awards |
CHORI/UC Berkeley Summer Stem Cell Research Internship Program for High School Students |
$151,046 |
Stanford University |
Paul J. Utz |
Creativity Awards |
SIMR Program: Stem Cell & Developmental Biology Research Internships |
$340,611 |
Scripps Research Institute |
James R Williamson |
Creativity Awards |
Stem Cell Summer Academy: Creating the Next Generation of Scientists |
$205,122 |
University of Southern California |
Roberta Diaz Brinton |
Creativity Awards |
CIRM STAR High School Summer Research and Creativity Program |
$271,160 |
University of California, San Diego |
George Sen |
Basic Biology IV |
Regulation of Epidermal Self-Renewal and Differentiation by Histone and DNA Demethylases. |
$1,080,000 |
Gladstone Institutes, J. David |
Dr. Benoit Bruneau |
Basic Biology IV |
Epigenetic regulation of human cardiac differentiation |
$1,568,148 |